Bowel Resection | Norton Healthcare

Indication: Bowel Resection

A phase 2, multicenter, randomized, double-blind, placebo-controlled study of naldemedine in patients undergoing surgeries that include a bowel resection or bowel transection

Sub-indication: Bowel Resection

Drug Study

Principal Investigator: Robert Martin, M.D., Ph.D.
University of Louisville Physicians - Surgical Oncology

Sponsor: Shionogi Inc

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.